Biodesix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biodesix and other ETFs, options, and stocks.

About BDSX

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. 

CEO
Scott Hutton
CEOScott Hutton
Employees
273
Employees273
Headquarters
Louisville, Colorado
HeadquartersLouisville, Colorado
Founded
2005
Founded2005
Employees
273
Employees273

BDSX Key Statistics

Market cap
71.12M
Market cap71.12M
Price-Earnings ratio
-1.66
Price-Earnings ratio-1.66
Dividend yield
Dividend yield
Average volume
8.07M
Average volume8.07M
High today
$9.10
High today$9.10
Low today
$7.61
Low today$7.61
Open price
$7.94
Open price$7.94
Volume
417.07K
Volume417.07K
52 Week high
$23.56
52 Week high$23.56
52 Week low
$3.44
52 Week low$3.44

Stock Snapshot

Biodesix(BDSX) stock is priced at $9.05, giving the company a market capitalization of 71.12M. It carries a P/E multiple of -1.66.

On 2026-01-21, Biodesix(BDSX) stock traded between a low of $7.61 and a high of $9.10. Shares are currently priced at $9.05, which is +18.9% above the low and -0.5% below the high.

Biodesix(BDSX) shares are trading with a volume of 417.07K, against a daily average of 8.07M.

During the past year, Biodesix(BDSX) stock moved between $3.44 at its lowest and $23.56 at its peak.

During the past year, Biodesix(BDSX) stock moved between $3.44 at its lowest and $23.56 at its peak.

People also own

Based on the portfolios of people who own BDSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .